Overslaan en naar de inhoud gaan

 Wetenschapelijke artikelen

FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.

Auteurs : Gombos A, Venet D, Ameye L, Vuylsteke P, Neven P, Richard V, Duhoux FP, Laes JF, Rothe F, Sotiriou C, Paesmans M, Awada A, Guiot T, Flamen P, Piccart-Gebhart M, Ignatiadis M, Gebhart G
Jaar : 2021
Journal : NPJ Breast Cancer
Volume : 7
Pagina's : 125

Circulating Tumor DNA to Interrogate the Safety of Letrozole-Associated Controlled Ovarian Stimulation for Fertility Preservation in Breast Cancer Patients.

Auteurs : Rothé F, Lambertini M, Goldrat O, Maetens M, Bareche Y, Blanc J, Rouas G, Larsimont D, Sotiriou C, Ignatiadis M, Demeestere I
Jaar : 2021
Journal : Front Oncol
Volume : 11
Pagina's : 686625

Neo-CheckRay: radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trial.

Auteurs : De Caluwé A, Buisseret L, Poortmans P, Van Gestel D, Salgado R, Sotiriou C, Larsimont D, Paesmans M, Craciun L, Drisis S, Vandekerckhove C, Reyal F, Veys I, Eiger D, Piccart-Gebhart M, Romano E, Ignatiadis M
Jaar : 2021
Journal : BMC Cancer
Volume : 21
Pagina's : 899

Niraparib for Advanced Breast Cancer with Germline <i>BRCA1</i> and <i>BRCA2</i> Mutations: the EORTC 1307-BCG/BIG5-13/TESARO PR-30-50-10-C BRAVO Study.

Auteurs : Turner NC, Balmaña J, Poncet C, Goulioti T, Tryfonidis K, Honkoop AH, Zoppoli G, Razis E, Johannsson OT, Colleoni M, Tutt AN, Audeh W, Ignatiadis M, Mailliez A, Trédan O, Musolino A, Vuylsteke P, Juan-Fita MJ, Macpherson IRJ, Kaufman B, Manso L, Goldstein LJ, Ellard SL, Láng I, Jen KY, Adam V, Litière S, Erban J, Cameron DA
Jaar : 2021
Journal : Clin Cancer Res
Volume : 27
Pagina's : 5482-5491

Cell-free circulating tumor DNA profiling in cancer management.

Auteurs : Roy D, Lucci A, Ignatiadis M, Jeffrey SS
Jaar : 2021
Journal : Trends Mol Med

Optimal treatment for aromatase inhibitor-resistant metastatic breast cancer patients: lessons from the PEARL study.

Auteurs : Agostinetto E, Ignatiadis M
Jaar : 2021
Journal : Ann Oncol
Volume : 32
Pagina's : 427-430

Liquid biopsy enters the clinic - implementation issues and future challenges.

Auteurs : Ignatiadis M, Sledge GW, Jeffrey SS
Jaar : 2021
Journal : Nat Rev Clin Oncol
Volume : 18
Pagina's : 297-312

Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients.

Auteurs : Bohlok A, Vermeulen P, Leduc S, Latacz E, Botzenhart L, Richard F, De Schepper M, Geukens T, Lucidi V, Ignatiadis M, Aftimos P, Sotiriou C, Piccart-Gebhart M, Hendlisz A, Van Laere S, Dirix L, Noël JC, Biganzoli E, Larsimont D, Desmedt C, Donckier V
Jaar : 2020
Journal : NPJ Breast Cancer
Volume : 6
Pagina's : 64

Cyclin-dependent kinases 4 and 6 inhibitors (CDK4/6i) versus chemotherapy in luminal B early breast cancer: lessons from the CORALLEEN trial.

Auteurs : de Angelis C, Ignatiadis M, Piccart-Gebhart M
Jaar : 2020
Journal : Ann Transl Med
Volume : 8
Pagina's : 1338

Neoadjuvant immunotherapy in breast cancer: a paradigm shift?

Auteurs : Fountzila E, Ignatiadis M
Jaar : 2020
Journal : Ecancermedicalscience
Volume : 14
Pagina's : 1147

Clinical management of first-line advanced triple-negative breast cancer patients

Auteurs : Rediti M, Punie K, de Azambuja E, Naert E, Taylor D, Duhoux FP, Denys H, Awada A, Wildiers H, Ignatiadis M
Jaar : 2020
Journal : Belgian J Medical Oncology
Volume : 14(7)
Pagina's : 333-338